Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $316.1 million.

  • Icu Medical's Accumulated Expenses fell 295.49% to $316.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $316.1 million, marking a year-over-year decrease of 295.49%. This contributed to the annual value of $306.9 million for FY2024, which is 1443.17% up from last year.
  • As of Q3 2025, Icu Medical's Accumulated Expenses stood at $316.1 million, which was down 295.49% from $313.8 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Accumulated Expenses registered a high of $325.7 million during Q3 2024, and its lowest value of $79.1 million during Q1 2021.
  • Over the past 5 years, Icu Medical's median Accumulated Expenses value was $251.3 million (recorded in 2023), while the average stood at $235.3 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 3412.49% in 2021, then soared by 23118.3% in 2022.
  • Icu Medical's Accumulated Expenses (Quarter) stood at $118.2 million in 2021, then skyrocketed by 105.4% to $242.8 million in 2022, then increased by 10.48% to $268.2 million in 2023, then grew by 14.43% to $306.9 million in 2024, then increased by 2.99% to $316.1 million in 2025.
  • Its Accumulated Expenses was $316.1 million in Q3 2025, compared to $313.8 million in Q2 2025 and $278.9 million in Q1 2025.